Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2017-01-31
2020-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Testing of recruitment, retention, consent, and assignment procedures
* Validating the inclusion/exclusion criteria
* Determining the acceptability and safety of the proposed intervention
* Evaluating implementation procedures and methodology for the intervention
* Evaluating the appropriateness of timing and frequency of data collection points
* Evaluating the appropriateness and feasibility of the assessment tools
* Obtaining parameters for sample size estimation for the larger study
* Assessing the effectiveness of the video medium, content in the video and length of the video
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Suicide prevention video
In this group, in addition to receiving the standard of care for their suicidality, the participants will also view a suicide prevention video.
Suicide prevention video
The video has been developed by the research team as an educational tool to teach patients about suicide, the consequences of such and imparting a message of hope.
Standard suicide treatment
The standard suicide treatment will be determine by the attending physician and can include medications and/or psychotherapy
Standard suicide treatment
In this group, participants will only receive the standard of care for their suicidality, which can include medications and/or therapy. The care will be determine by their attending physician.
Standard suicide treatment
The standard suicide treatment will be determine by the attending physician and can include medications and/or psychotherapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Suicide prevention video
The video has been developed by the research team as an educational tool to teach patients about suicide, the consequences of such and imparting a message of hope.
Standard suicide treatment
The standard suicide treatment will be determine by the attending physician and can include medications and/or psychotherapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to the Royal Columbian Hospital under psychiatric services
* Individuals will have had suicidal behaviours as part of their presentation leading to hospitalization
* Individuals must be at the level 2 observation privileges or higher
* Individuals must be capable of giving consent to participate in the study
* Individuals must speak and read English fluently Individuals admitted to the hospital as voluntary and involuntary (certified) patients
Exclusion Criteria
* Individuals who are under the influence of drugs, such as intoxication or active withdrawal
* Individuals with established diagnoses of cognitive impairment affecting their ability to give consent, understand what is expected of them in the study or follow directions
* Patients that require a substitute decision makers to provide consent
* Individuals whose behaviors an/or cognition are actively affected by ongoing psychosis, including hallucinations, delusions, and disorganized behaviors
* Individuals whose treating team assess them as likely to have a negative response to the SPV, for example paranoia around electronic devices
* Patient's who's attending physiatrist is one of the study team members
* Patients who are currently under the direct care of any of the investigators Patients that had acute suicidality in the last 24 hours
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fraser Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hem Phaterpekar, MD
Role: PRINCIPAL_INVESTIGATOR
Fraser Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royal Columbian and Eagle Ridge Hospitals
New Westminster, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FHREB 2015-141
Identifier Type: -
Identifier Source: org_study_id